Pulse Biosciences Inc
PLSE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.73B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.73 Billion |
|---|---|
| Enterprise Value | $3.70 Billion |
| Earnings per Share | $-1.08 |
| Beta | 1.57 |
| Outstanding Shares | 69,200,020 |
Return
| Return on Equity | -45.61% |
|---|---|
| Return on Assets | -41.53% |
| Return on Invested Capital | -44.92% |
Valuation & Multiples
| P/E Ratio | -44.65 |
|---|---|
| PEG | -236.1 |
| Price to Sales | - |
| Price to Book Ratio | 26.65 |
| Enterprise Value to Revenue | 3230.36 |
| Enterprise Value to EBIT | -43.71 |
| Enterprise Value to Net Income | -45 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS Estimate
$-0.31
Consensus analyst estimateRevenue Estimate
$520,833
Consensus analyst estimateNext Earnings Call
Expected Date
February 18, 2027
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
$695,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 30.47% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.28%▼ 15.42% |
|---|---|
| Total Invested | $9.79M▼ 96.75% |
| Investors Holding | 26▼ 86.00% |
About Pulse Biosciences Inc
95 employees
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive ad...